{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:47:56Z","timestamp":1794473276925,"version":"4.9.1"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2023YFC2606500"],"award-info":[{"award-number":["2023YFC2606500"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010040","name":"Taishan Scholar Project of Shandong Province","doi-asserted-by":"publisher","award":["tsqn202103108"],"award-info":[{"award-number":["tsqn202103108"]}],"id":[{"id":"10.13039\/501100010040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010040","name":"Taishan Scholar Project of Shandong Province","doi-asserted-by":"publisher","award":["tstp20240852"],"award-info":[{"award-number":["tstp20240852"]}],"id":[{"id":"10.13039\/501100010040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M761823"],"award-info":[{"award-number":["2024M761823"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejmech.2025.118208","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T20:09:29Z","timestamp":1759262969000},"page":"118208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Antiviral strategies based on targeted protein degradation: An overview of the literature and future outlook"],"prefix":"10.1016","volume":"301","author":[{"given":"Fan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dazhou","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baohu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7168-613X","authenticated-orcid":false,"given":"Peng","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118208_bib3","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01604-22","article-title":"SARS-CoV-2 variant Delta potently suppresses innate immune response and evades interferon-activated antiviral responses in human colon epithelial cells","volume":"10","author":"Tandel","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.ejmech.2025.118208_bib4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41590-024-02051-0","article-title":"T cell immune evasion by SARS-CoV-2 JN.1 escapees targeting two cytotoxic T cell epitope hotspots","volume":"26","author":"Tian","year":"2025","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejmech.2025.118208_bib6","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41575-023-00760-9","article-title":"Global burden of hepatitis B virus: current status, missed opportunities and a call for action","volume":"20","author":"Hsu","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejmech.2025.118208_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymthe.2025.08.033","article-title":"Targeted degradation of the HPV oncoprotein E6 reduces tumor burden in cervical cancer","author":"Smalley","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejmech.2025.118208_bib11","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41580-024-00729-9","article-title":"Targeted protein degradation: from mechanisms to clinic","volume":"25","author":"Tsai","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.118208_bib12","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/s41564-025-01940-w","article-title":"ARF4-mediated intracellular transport as a broad-spectrum antiviral target","volume":"10","author":"Li","year":"2025","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ejmech.2025.118208_bib13","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2414202122","article-title":"Shared host genetic landscape of respiratory viral infection","volume":"122","author":"Soriaga","year":"2025","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejmech.2025.118208_bib14","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.chembiol.2024.11.002","article-title":"An engineered cereblon optimized for high-throughput screening and molecular glue discovery","volume":"32","author":"Bailey","year":"2025","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.118208_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.22145","article-title":"Proteolysis-targeting chimeras in antiviral therapy: leveraging influenza virus and exosome-mediated delivery for targeted protein degradation and therapeutic advancements","volume":"85","author":"Mukerjee","year":"2024","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejmech.2025.118208_bib16","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0140-6736(24)01698-2","article-title":"Antiviral treatment and prophylaxis for influenza","volume":"404","author":"Hui","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2025.118208_bib17","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41591-024-03419-3","article-title":"Single-dose suraxavir marboxil for acute uncomplicated influenza in adults and adolescents: a multicenter, randomized, double-blind, placebo-controlled phase 3 trial","volume":"31","author":"Wang","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2025.118208_bib18","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1038\/s41467-022-29690-x","article-title":"An anti-influenza A virus microbial metabolite acts by degrading viral endonuclease PA","volume":"13","author":"Zhao","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.118208_bib19","doi-asserted-by":"crossref","first-page":"8791","DOI":"10.1021\/acs.jmedchem.4c00131","article-title":"Novel acyl thiourea-based hydrophobic tagging degraders exert potent anti-influenza activity through two distinct endonuclease polymerase acidic-targeted degradation pathways","volume":"67","author":"Ma","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118208_bib20","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.immuni.2025.02.006","article-title":"Antigenic drift expands influenza viral escape pathways from recalled humoral immunity","volume":"58","author":"Maurer","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.ejmech.2025.118208_bib21","doi-asserted-by":"crossref","first-page":"7154","DOI":"10.1021\/acs.jmedchem.1c02013","article-title":"Discovery of pentacyclic triterpenoid PROTACs as a class of effective hemagglutinin protein degraders","volume":"65","author":"Li","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118208_bib22","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.immuni.2024.02.003","article-title":"Protective human monoclonal antibodies target conserved sites of vulnerability on the underside of influenza virus neuraminidase","volume":"57","author":"Lederhofer","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.ejmech.2025.118208_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellin.2022.100030","article-title":"Discovery of oseltamivir-based novel PROTACs as degraders targeting neuraminidase to combat H1N1 influenza virus","volume":"1","author":"Xu","year":"2022","journal-title":"Cell Insight"},{"key":"10.1016\/j.ejmech.2025.118208_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110736","article-title":"Disrupting the HDAC6-ubiquitin interaction impairs infection by influenza and Zika virus and cellular stress pathways","volume":"39","author":"Wang","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2025.118208_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2025.123401","article-title":"Pharmacologically induced proteolysis of histone deacetylase-6 attenuates influenza virus replication despite limited anti-tumor effects","author":"Jungwirth","year":"2025","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2025.118208_bib26","article-title":"Molecular patterns of matrix protein 1 (M1): a strong predictor of adaptive evolution in H9N2 avian influenza viruses","volume":"122","author":"Zhu","year":"2025","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejmech.2025.118208_bib27","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/s41587-022-01381-4","article-title":"Generation of a live attenuated influenza A vaccine by proteolysis targeting","volume":"40","author":"Si","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejmech.2025.118208_bib28","article-title":"PROTAR Vaccine 2.0 generates influenza vaccines by degrading multiple viral proteins","author":"Zhang","year":"2025","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118208_bib29","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1038\/s41467-024-49161-9","article-title":"Broad-spectrum activity against mosquito-borne flaviviruses achieved by a targeted protein degradation mechanism","volume":"15","author":"Liu","year":"2024","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118208_bib30","first-page":"103","article-title":"Understanding hepatitis C virus drug resistance: clinical Implications for current and future regimens","volume":"25","author":"Wyles","year":"2017","journal-title":"Top. Antivir. Med."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118208_bib31","doi-asserted-by":"crossref","first-page":"7457","DOI":"10.1038\/s41467-023-42550-6","article-title":"Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.118208_bib32","doi-asserted-by":"crossref","first-page":"7998","DOI":"10.1021\/acs.jcim.4c01206","article-title":"Molecular mechanism-driven discovery of novel small molecule inhibitors against drug-resistant SARS-CoV-2 Mpro variants","volume":"64","author":"Yang","year":"2024","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2025.118208_bib33","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.4c03024","article-title":"Development of orally bioavailable Octahydroindole-based peptidomimetic derivative as a broad-spectrum inhibitor against HCoV-OC43 and SARS-CoV-2","author":"Hu","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118208_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113814","article-title":"Indomethacin-based PROTACs as pan-coronavirus antiviral agents","volume":"226","author":"Desantis","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118208_bib35","author":"Zhang"},{"key":"10.1016\/j.ejmech.2025.118208_bib36","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/s41564-024-01618-9","article-title":"Preclinical evaluation of the SARS-CoV-2 Mpro inhibitor RAY1216 shows improved pharmacokinetics compared with nirmatrelvir","volume":"9","author":"Chen","year":"2024","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ejmech.2025.118208_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103847","article-title":"Targeted degrader technologies as prospective SARS-CoV-2 therapies","volume":"29","author":"Khurshid","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2025.118208_bib38","doi-asserted-by":"crossref","first-page":"27248","DOI":"10.1021\/jacs.3c12678","article-title":"A chemical strategy for the degradation of the main protease of SARS-CoV-2 in cells","volume":"145","author":"Sang","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.118208_bib39","article-title":"Discovery of an antiviral PROTAC targeting the SARS-CoV-2 main protease using an allosteric warhead","author":"Veeck","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.ejmech.2025.118208_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116202","article-title":"Design, synthesis, and biological evaluation of first-in-class indomethacin-based PROTACs degrading SARS-CoV-2 main protease and with broad-spectrum antiviral activity","volume":"268","author":"Desantis","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118208_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116629","article-title":"Development of novel antiviral agents that induce the degradation of the main protease of human-infecting coronaviruses","volume":"275","author":"Cheng","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2025.118208_bib42","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.3390\/biom14101260","article-title":"A structural investigation of the interaction between a GC-376-based peptidomimetic PROTAC and its precursor with the viral main protease of Coxsackievirus B3","volume":"14","author":"De Santis","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2025.118208_bib43","first-page":"140","article-title":"Targeted protein degraders of SARS-CoV-2 Mpro are more active than enzymatic inhibition alone with activity against nirmatrelvir resistant virus, Commun","volume":"5","author":"Pan","year":"2025","journal-title":"M\u00e9d. Sur"},{"key":"10.1016\/j.ejmech.2025.118208_bib44","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1021\/acsmedchemlett.3c00498","article-title":"Development of a GC-376 based peptidomimetic PROTAC as a degrader of 3-Chymotrypsin-like protease of SARS-CoV-2","volume":"15","author":"Grifagni","year":"2024","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118208_bib45","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1053\/j.gastro.2018.10.024","article-title":"Status of direct-acting antiviral therapy for hepatitis C virus infection and remaining challenges","volume":"156","author":"Baumert","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejmech.2025.118208_bib46","doi-asserted-by":"crossref","first-page":"7073","DOI":"10.3390\/ijms25137073","article-title":"After the storm: persistent molecular alterations following HCV cure","volume":"25","author":"Seurre","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118208_bib47","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.coph.2016.07.015","article-title":"Hepatitis C virus NS3\/4a protease inhibitors","volume":"30","author":"McCauley","year":"2016","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118208_bib48","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41575-022-00608-8","article-title":"Breakthroughs in hepatitis C research: from discovery to cure","volume":"19","author":"Manns","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejmech.2025.118208_bib49","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1038\/s41467-019-11429-w","article-title":"Small molecule degraders of the hepatitis C virus protease reduce susceptibility to resistance mutations","volume":"10","author":"de Wispelaere","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.118208_bib50","first-page":"59","article-title":"Hepatitis C: milestones from discovery to clinical cure","volume":"7","author":"Hu","year":"2020","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.ejmech.2025.118208_bib51","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.4c02068","article-title":"Targeted degradation of HCV polymerase by GalNAc-conjugated ApTACs for pan-genotypic antiviral therapy with high resistance barriers","author":"Pan","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118208_bib52","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1016\/S2352-3018(24)00063-8","article-title":"Non-suppressible viraemia during HIV-1 therapy: a challenge for clinicians","volume":"11","author":"Esteban-Cantos","year":"2024","journal-title":"Lancet HIV"},{"key":"10.1016\/j.ejmech.2025.118208_bib53","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abn8359","article-title":"The HIV-1 protein Nef activates the Tec family kinase Btk by stabilizing an intermolecular SH3-SH2 domain interaction","volume":"15","author":"Aryal","year":"2022","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ejmech.2025.118208_bib54","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1684\/vir.2022.0940","article-title":"Inhibitors of HIV-1 Nef: applications and developments for a practical cure","volume":"26","author":"Lurie","year":"2022","journal-title":"Virologie"},{"key":"10.1016\/j.ejmech.2025.118208_bib55","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.chembiol.2024.02.004","article-title":"PROTAC-mediated degradation of HIV-1 Nef efficiently restores cell-surface CD4 and MHC-I expression and blocks HIV-1 replication","volume":"31","author":"Emert-Sedlak","year":"2024","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.118208_bib56","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1038\/s41591-021-01590-5","article-title":"International AIDS society (IAS) global scientific strategy working group, research priorities for an HIV cure: international AIDS society global scientific strategy 2021","volume":"27","author":"Deeks","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2025.118208_bib57","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1038\/s41594-024-01314-6","article-title":"Structural insights into PPP2R5A degradation by HIV-1 Vif","volume":"31","author":"Hu","year":"2024","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejmech.2025.118208_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2024.129880","article-title":"Discovery of L15 as a novel Vif PROTAC degrader with antiviral activity against HIV-1","volume":"111","author":"Luo","year":"2024","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118208_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-15993-y","article-title":"Directing HIV-1 for degradation by non-target cells, using bi-specific single-chain llama antibodies","volume":"12","author":"Stam","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.118208_bib60","doi-asserted-by":"crossref","DOI":"10.1136\/egastro-2023-100021","article-title":"Opportunities and challenges for hepatitis B cure","volume":"1","author":"Roca Suarez","year":"2023","journal-title":"eGastroenterology"},{"key":"10.1016\/j.ejmech.2025.118208_bib61","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-981-13-9151-4_2","article-title":"HBV genome and life cycle","volume":"1179","author":"Wang","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejmech.2025.118208_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2024.129680","article-title":"\u201cPROTAC\u201d modified dihydroquinolizinones (DHQs) that cause degradation of PAPD-5 and inhibition of hepatitis A virus and hepatitis B virus, in vitro","volume":"102","author":"Li","year":"2024","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118208_bib63","doi-asserted-by":"crossref","first-page":"7897","DOI":"10.1021\/jacs.4c18398","article-title":"A dual-targeted molecule for disease-activatable proteolysis targeting chimeras and targeted radionuclide therapy of cancer","volume":"147","author":"Zhang","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.118208_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105552","article-title":"Screening of an epigenetic compound library identifies BRD4 as a potential antiviral target for hepatitis B virus covalently closed circular DNA transcription","volume":"211","author":"Yu","year":"2023","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2025.118208_bib65","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev-virology-110615-042238","article-title":"The structural biology of hepatitis B virus: form and function","volume":"3","author":"Venkatakrishnan","year":"2016","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.ejmech.2025.118208_bib66","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/j.apsb.2025.02.033","article-title":"Discovery and mechanism verification of first-in-class hydrophobic tagging-based degraders of HBV core protein","volume":"15","author":"Xu","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2025.118208_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312858","article-title":"Development of a PROTAC-based targeting strategy provides a mechanistically unique mode of anti-cytomegalovirus activity","volume":"22","author":"Hahn","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118208_bib68","first-page":"285","article-title":"Recent advances in the molecular design and applications of proteolysis targeting chimera-based multi-specific antiviral modality","volume":"2","author":"Zhou","year":"2023","journal-title":"Acta Mater. Med"},{"key":"10.1016\/j.ejmech.2025.118208_bib69","article-title":"Harnessing molecular proximity for antiviral innovations: advances in proximity-inducing modalities against viral infections","author":"Wu","year":"2025","journal-title":"Sci. China Chem."},{"key":"10.1016\/j.ejmech.2025.118208_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.apsb.2025.08.024","article-title":"Protein degradation-based anti-infective drug research","author":"Shi","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"issue":"15","key":"10.1016\/j.ejmech.2025.118208_bib71","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adl4393","article-title":"Developing nucleoside tailoring strategies against SARS-CoV-2 via ribonuclease targeting chimera","volume":"10","author":"Min","year":"2024","journal-title":"Sci. Adv."},{"issue":"5","key":"10.1016\/j.ejmech.2025.118208_bib72","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1021\/acscentsci.3c00015","article-title":"Proximity-induced nucleic acid degrader (PINAD) approach to targeted RNA degradation using small molecules","volume":"9","author":"Mikutis","year":"2023","journal-title":"ACS Cent. Sci."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425009730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425009730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T09:54:06Z","timestamp":1773136446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425009730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":66,"alternative-id":["S0223523425009730"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118208","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiviral strategies based on targeted protein degradation: An overview of the literature and future outlook","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118208","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118208"}}